Literature DB >> 31062612

Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells.

Xiaohua Fu1, Jing Zhu1, Lin Zhang1, Jing Shu1.   

Abstract

Hepatic steatosis is one of the most important features of the pathogenesis for non-alcoholic fatty liver disease. Fat deposition in liver cells can influence hepatic lipogenesis along with other metabolic pathways and further lead to the irreversible liver cirrhosis and injury. However, the underlying mechanism of steatosis remains largely unexplored. Our previous study revealed that AQP7 played an important role in liver steatosis. In this study, we determined that the transcriptional level of AQP7 was up-regulated by estrogen receptor alpha (ERα) upon 17β-estradiol (E2) and oleic acids treated HepG2 cells. Furthermore, we identified long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) as a potential hallmark which was down-regulated in ERα silencing HepG2 cells by RNA-Seq. Finally, we validated that the 3' terminal nucleotides of NEAT1 were contributed for the interaction with ERα to facilitate AQP7 transcription to suppress liver steatosis. Overall, our study gave evidence that NEAT1 played an important role in the activation of ERα to regulate AQP7-mediated hepatic steatosis.

Entities:  

Keywords:  AQP7; NEAT1; estrogen receptor; steatosis

Mesh:

Substances:

Year:  2019        PMID: 31062612     DOI: 10.1080/21691401.2019.1604536

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  7 in total

Review 1.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

Review 2.  Molecular Interactions of the Long Noncoding RNA NEAT1 in Cancer.

Authors:  Jingtao Gu; Bo Zhang; Rui An; Weikun Qian; Liang Han; Wanxing Duan; Zheng Wang; Qingyong Ma
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

Review 3.  Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease.

Authors:  Mohamed Zaiou
Journal:  World J Gastroenterol       Date:  2022-09-21       Impact factor: 5.374

Review 4.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

5.  Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4.

Authors:  Khaoula Errafii; Neyla S Al-Akl; Olfa Khalifa; Abdelilah Arredouani
Journal:  J Transl Med       Date:  2021-06-02       Impact factor: 5.531

6.  Mitochondrial dysfunction promotes aquaporin expression that controls hydrogen peroxide permeability and ferroptosis.

Authors:  Yuko Takashi; Kazuo Tomita; Yoshikazu Kuwahara; Mehryar Habibi Roudkenar; Amaneh Mohammadi Roushandeh; Kento Igarashi; Taisuke Nagasawa; Yoshihiro Nishitani; Tomoaki Sato
Journal:  Free Radic Biol Med       Date:  2020-10-02       Impact factor: 7.376

Review 7.  A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease.

Authors:  Arezoo Gowhari Shabgah; Fatemeh Norouzi; Mahdiyeh Hedayati-Moghadam; Davood Soleimani; Naseh Pahlavani; Jamshid Gholizadeh Navashenaq
Journal:  Nutr Metab (Lond)       Date:  2021-02-23       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.